ENTRY       D00358                      Drug
NAME        Lidocaine (JP17/USP/INN);
            Dentipatch (TN);
            Xylocaine (TN)
PRODUCT     LIDODERM (Aidarex Pharmaceuticals LLC) 67a10009-085a-4d45-89bb-36907bfc0f63
            LIDODERM (Bryant Ranch Prepack) 165845cf-c59c-4dbe-af8f-ecb92a1fcdc6
            LIDOCAINE (DIRECT RX) 2f1e77e1-86b6-635e-e054-00144ff88e88
            LIDODERM (Dispensing Solutions) 55be87b4-a69b-4bfd-bf92-2949ec5e5dab
            LIDODERM (Endo Pharmaceuticals) f1c40164-4626-4290-9012-c00e33420a33
            LIDODERM (H.J. Harkins Company) 7e7e03ba-5035-4e6d-9aa0-a00c8d3e0d87
            LIDODERM (Physicians Total Care) 5ffefcdc-ebfa-4dc8-b484-719658da9d6d
            LIDODERM (Rebel Distributors Corp.) 18e420b9-0fd1-48d9-9a23-c1e29a5f629f
            LIDODERM (STAT RX USA LLC) 7ab30afe-4de2-4fe5-9e62-a484683fb93f
            LIDODERM (STAT Rx USA LLC) 4e45cd6c-a777-4100-943b-985058bff75a
            LIDODERM 5 (St Marys Medical Park Pharmacy) 22e92e0a-77ad-4128-8ea9-28766297026a
            LIDODERM (Unit Dose Services) d499efc5-8bc3-4dbc-9d85-fae57dd9263c
            LIDODERM (Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC) 09be2cbc-73bf-4894-add6-10e46c4471c9
  GENERIC   LIDOCAINE (Actavis Pharma) 4d04052c-3e0a-469a-9265-99604f13e507
            LIDOCAINE (Actavis Pharma) c18799cd-9e11-4196-9ab1-0a2a84585e56
            LIDOCAINE (Aidarex Pharmaceuticals LLC) 2583149a-9efd-418d-89eb-c439b8752d26
            LIDOCAINE (Aidarex Pharmaceuticals LLC) 670287ac-9d8d-4514-b433-4adcca2d915a
            LIDOCAINE (Amneal Pharmaceuticals LLC) d1509740-f9f1-44e3-8fde-51d8683fcd87
            LIDOCAINE (Ascend Laboratories) e2748dfb-bffe-47a8-a886-853d0f7c910a
            LIDOCAINE (AvKARE) 37ce4a6b-fd0d-8800-4e94-1ed65f6d4361
            LIDOCAINE (AvKARE) 42abc81b-668f-7ec4-f37f-bdc5ac43465d
            LIDOCAINE (Bryant Ranch Prepack) 4e856dd5-f2fa-4acb-a205-f87baf26b8cc
            LIDOCAINE (Bryant Ranch Prepack) 6d7fdc43-e493-449e-9af6-825e584b547a
            LIDOCAINE (Cardinal Health) eb808fdf-0420-45e9-ad17-8380d49d5c21
            LIDOCAINE (Cardinal Health) fa69dfdf-ab73-48a9-944d-25e88d7766df
            LIDOCAINE (DIRECT RX) 8112b45f-b6b3-4c68-bbd0-4a6d65d73bbe
            LIDOCAINE (E. Fougera & Co. a division of Fougera Pharmaceuticals) 88ca9cba-0c4a-482f-b502-ceefdb1bfbcd
            LIDOCAINE (Gemini Laboratories) 2dc8a3a2-380b-5219-e054-00144ff88e88
            LIDOCAINE (Glenmark Pharmaceuticals) eaa15be7-11ea-49bc-ac07-739075453be6
            LIDOCAINE (Hi-Tech Pharmacal) f130a654-ee3b-4daa-8dc6-8f514edf75a1
            LIDOCAINE (IPG PHARMACEUTICALS) 6fa78380-99ac-4db0-9634-7eb849c6852e
            LIDOCAINE (IPG Pharmaceuticals) a2e56162-2d2f-434c-8581-c7b3f68192b6
            LIDOCAINE (Ingenus Pharmaceuticals) c8fdd304-af9e-4f43-8798-7366000a06d1
            LIDOCAINE (Lake Erie Medical DBA Quality Care Products LLC) 0463d73a-f336-4e6d-81ea-c0321e1a52f5
            LIDOCAINE (Lake Erie Medical DBA Quality Care Products LLC) 42626da9-8117-4f95-8b3d-f675e0affb43
            LIDOCAINE (Lake Erie Medical DBA Quality Care Products LLC) 6b9ba38c-7df4-4e95-814e-c58d99ccae17
            LIDOCAINE (Lake Erie Medical DBA Quality Care Products LLC) c1444ba1-fd4e-489f-a712-b84b1642e1e3
            LIDOCAINE (Lake Erie Medical DBA Quality Care Products LLC) f20ab860-e49a-4f3f-868e-6a60780af5a7
            LIDOCAINE (Liberty Pharmaceuticals) 7e81c577-5a08-4c97-93e1-7a05c2f7c237
            LIDOCAINE (Mylan Pharmaceuticals) 5c66f3b9-6e04-47ab-8d94-21e89ceec154
            LIDOCAINE (Novocol) c66b3509-c670-4124-86ac-da313958aabd
            LIDOCAINE (Pharmaceutica North America) 22693fd1-f831-49af-a389-26504e5db2eb
            LIDOCAINE (Pharmaceutica North America) 327c573b-27b3-694d-e054-00144ff88e88
            LIDOCAINE (Preferred Pharmaceuticals) 1f6e2cff-e6fe-4958-9043-2ca6bdf5e2be
            LIDOCAINE (Preferred Pharmaceuticals) 3d30e6d2-75af-4bd3-83a6-a657585bc90e
            LIDOCAINE (Preferred Pharmaceuticals) 4380d23a-5467-457d-943b-56a8cb6ca1a6
            LIDOCAINE (Preferred Pharmaceuticals) 4806f94d-cbac-4107-b93b-8f715868ffb3
            LIDOCAINE (Preferred Pharmaceuticals) 8819365a-d1e8-4966-b83a-4ec472c5158c
            LIDOCAINE (Preferred Pharmaceuticals) b522f1d0-045a-4e9c-9de9-87190503ea89
            LIDOCAINE (Preferred Pharmaceuticals) bc70bb9f-38c2-4a4a-9401-8ed11db413d9
            LIDOCAINE (Preferred Pharmaceuticals) cebbdd68-a913-4b64-940e-9d99b17acbcd
            LIDOCAINE (Proficient Rx LP) 2996f29c-880f-425a-9fdf-d2b3b5f62308
            LIDOCAINE (PureTek Corporation) 85e72943-6989-42f4-b519-a3ebbf4bc777
            LIDOCAINE (Qualitest Pharmaceuticals) 2ce8a4fe-8aa6-4dc5-ad0f-3984ae68c4bc
            LIDOCAINE (REMEDYREPACK) 94ab1b99-e203-4a14-b852-42d3b37999c3
            LIDOCAINE (Rebel Distributors Corp) a1e2c14f-0682-4b19-9159-de0aca1960c6
            LIDOCAINE (Septodont) 82a4c16f-d47e-479f-8f85-7d1be6fc2318
            LIDOPAC (Sterling-Knight Pharmaceuticals) b6ed830e-6548-4918-915f-c858d831e953
            LIDOCAINE (Sterling-Knight Pharmaceuticals) fbfd0cc7-2038-496b-b9ca-f3327f38bde7
            LIDOCAINE (Taro Pharmaceuticals U.S.A.) 5eb2c62f-5352-41d7-bd66-c65b1988a9ab
            LIDOCAINE (Taro Pharmaceuticals U.S.A.) ae758020-a508-4a2e-8164-e6c324e826a3
            LIDOCAINE (Teligent Pharma) 12639881-632d-445d-9ff5-b84567f49179
            LIDOCAINE (Unit Dose Services) 03bd61bf-85a7-4963-8f06-57fd6d48a4e8
            LIDOCAINE (Unit Dose Services) 20b8df6b-34d3-468c-9726-39fe947da274
            LIDOCAINE HYDROCHLORIDE (Unit Dose Services) 10435379-1bb2-4023-98a7-ee4f28d620fd
            LIDOCAINE (Solubiomix) a18d2e07-fe58-4641-b03b-d9d56642f13c
  OTHER     LIDOCAINE HYDROCHLORIDE (Aidarex Pharmaceuticals LLC) 95ae61d8-d9a2-4e50-9065-c0cb97b95743
            PREMIUM LIDOCAINE 5% EXTRA (Alivio Medical Products) a7fd037b-28b2-4431-85e6-958b7ce49b78
            ASTERO (All Pharma) 832b0d7b-5610-4382-a88a-6d0a1f81a9ff
            BIO-SCRIPTIVES LIDUM TOPICAL ANALGESIC (Bio-Scriptives) a19bb9cc-b20b-4a15-9c82-dd2544cb252d
            ASTERO (Gensco Laboratories) 61ad536b-f333-4dc1-8b6e-1ebb1feb2a30
            LIDOCAINE HYDROCHLORIDE (Gensco Laboratories) 88dbd438-02c0-481a-bdb7-8b3f3c41fd46
            LIDO RX (Gensco Laboratories) 909baba8-9656-4769-97cf-b642982c3c9f
            LIDOCAINE HYDROCHLORIDE (Lake Erie Medical DBA Quality Care Products LLC) 4a4f6692-779b-4216-b3fb-3f961d5c80ed
            LIDOCAINE HYDROCHLORIDE (Lake Erie Medical DBA Quality Care Products LLC) 60afd3bd-4e0b-4d2f-807b-4f872147d527
            LIDOCAINE (MARTIN EKWEALOR PHARMACEUTICALS) 3ea9b7ae-b05a-4415-a451-05763b3c6ffd
            TRANZAREL (Taleos Pharma) 23a36261-98dc-40c9-9adf-99a43b6a9ddc
            LIDOCAINE (Two Hip Consulting) d5e2e8c0-48b3-4666-95a2-d9aef29f1a1c
            LIDOCAINE HYDROCHLORIDE (Unit Dose Services) 668477b0-2ab7-4b7d-be37-d4394799cd1c
FORMULA     C14H22N2O
EXACT_MASS  234.1732
MOL_WEIGHT  234.3373
CLASS       Cardiovascular agent
             DG01653  Antiarrhythmics
              DG01652  Class I antiarrhythmic agent
               DG01651  Class Ib antiarrhythmic agent
            Neuropsychiatric agent
             DG02030  Anesthetics
              DG01675  Local anesthetic
               DG01673  Amide type local anesthetic
             DG01675  Local anesthetic
              DG01673  Amide type local anesthetic
            Cyp substrate
             DG01892  CYP1A2 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A substrate
REMARK      Same as: C07073
            Therapeutic category: 1214
            ATC code: C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01
            Chemical group: DG00196
ACTIVITY    Anesthetic (topical), Antiarrhythmic, Sodium channel blocker
COMMENT     Class I antiarrhythmic agent (Ib)
            Anilide derivative
TARGET      SCN1A [HSA:6323] [KO:K04833];
            SCN2A [HSA:6326] [KO:K04834];
            SCN3A [HSA:6328] [KO:K04836];
            SCN4A [HSA:6329] [KO:K04837];
            SCN5A [HSA:6331] [KO:K04838];
            SCN8A [HSA:6334] [KO:K04840];
            SCN9A [HSA:6335] [KO:K04841];
            SCN10A [HSA:6336] [KO:K04842];
            SCN11A [HSA:11280] [KO:K04843]
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
            Transporter: SLC22A3 [HSA:6581]
INTERACTION  
STR_MAP     map07037  Antiarrhythmic drugs
            map07231  Sodium channel blocking drugs
OTHER_MAP   map00982  Drug metabolism - cytochrome P450
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BB Antiarrhythmics, class Ib
                 C01BB01 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AD Local anesthetics
                 C05AD01 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
             D DERMATOLOGICALS
              D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
               D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
                D04AB Anesthetics for topical use
                 D04AB01 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BB Amides
                 N01BB02 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
             R RESPIRATORY SYSTEM
              R02 THROAT PREPARATIONS
               R02A THROAT PREPARATIONS
                R02AD Anesthetics, local
                 R02AD02 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01H LOCAL ANESTHETICS
                S01HA Local anesthetics
                 S01HA07 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
              S02 OTOLOGICALS
               S02D OTHER OTOLOGICALS
                S02DA Analgesics and anesthetics
                 S02DA01 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
            USP drug classification [BR:br08302]
             Anesthetics
              Local Anesthetics
               Lidocaine
                D00358  Lidocaine (JP17/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               121  Local anesthetics
                1214  Xylidines
                 D00358  Lidocaine (JP17/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for  urogenital organs and anus
              30 Hemorrhoid drugs for external use
               D00358  Lidocaine (JP17/USP/INN)
             Agents for integumentary system
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D00358  Lidocaine (JP17/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Second-class OTC drugs
              Inorganic and organic chemicals
               Lidocaine
                D00358  Lidocaine (JP17/USP/INN)
            Pharmaceutical additives in Japan [BR:br08316]
             Soothing agent
              D00358  [001667] Lidocaine
             Solubilizer
              D00358  [001667] Lidocaine
             Solubilization agent
              D00358  [001667] Lidocaine
             Solvent
              D00358  [001667] Lidocaine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated cation channels
               Na+ channel, SCN alpha, NaV1.x
                voltage-gated sodium channel (SCN1A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN2A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN3A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN4A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN5A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN8A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN9A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN10A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
                voltage-gated sodium channel (SCN11A)
                 Lidocaine
                  D00358  Lidocaine (JP17/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP substrates
              CYP1A2
               Lidocaine
                D00358  Lidocaine (JP17/USP/INN)
              CYP2D6
               Lidocaine
                D00358  Lidocaine (JP17/USP/INN)
              CYP3A4
               Lidocaine
                D00358  Lidocaine (JP17/USP/INN)
             Transporter substrates
              SLC22A3
               Lidocaine
                D00358  Lidocaine (JP17/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00358  Lidocaine
              D00358  Lidocaine injection
            Anesthetics, analgesics and anti-inflammatory drugs [br08369.html]
             Anesthetics
              D00358
            Orphan drugs in the USA [br08355.html]
             Orphan drugs in the USA
              D00358
DBLINKS     CAS: 137-58-6
            PubChem: 7847424
            ChEBI: 6456
            ChEMBL: CHEMBL79
            DrugBank: DB00281
            PDB-CCD: LQZ
            LigandBox: D00358
            NIKKAJI: J5.631F
ATOM        17
            1   C8y C    23.2602  -19.0646
            2   N1b N    24.4935  -19.7778
            3   C8y C    22.0325  -19.7836
            4   C8y C    23.2602  -17.6441
            5   C5a C    25.7213  -19.0587
            6   C8x C    20.8049  -19.0646
            7   C1a C    22.0384  -21.1983
            8   C8x C    22.0325  -16.9367
            9   C1a C    24.4818  -16.9367
            10  C1b C    26.9488  -19.7778
            11  O5a O    25.7096  -17.6332
            12  C8x C    20.8049  -17.6441
            13  N1c N    28.1823  -19.0587
            14  C1b C    29.4158  -19.7778
            15  C1b C    28.1823  -17.6441
            16  C1a C    30.6317  -19.0587
            17  C1a C    29.4158  -16.9309
BOND        17
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    6  12 2
            12   10  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17    8  12 1
///
